Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 210.00
Bid: 204.00
Ask: 216.00
Change: 0.00 (0.00%)
Spread: 12.00 (5.882%)
Open: 210.00
High: 210.00
Low: 210.00
Prev. Close: 210.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Animalcare announces leadership change

3 Aug 2018 07:00

RNS Number : 7459W
Animalcare Group PLC
03 August 2018
 

 

3 August 2018

 

Animalcare Group plc

 

("Animalcare", the "Company" or the "Group")

 

Animalcare announces leadership change

 

Animalcare Group plc (AIM:ANCR), the pan-European animal health business, today announces that Chris Cardon will step down from his position as Chief Executive Officer. The Board has appointed Jenny Winter to succeed Chris as Chief Executive Officer with effect from 1 October 2018. Chris will remain on the Board of the Company as part of the executive management team, transitioning to Chief Strategy Officer as of 1 October 2018. Chris will continue to lead the Company's international strategic vision and acquisition strategy and be part of Jenny's leadership team.

Jenny joins Animalcare with over twenty years' experience working in big pharma in various senior commercial roles for AstraZeneca and GlaxoSmithKline. Most recently, Jenny was Vice-President of Respiratory products - Global Supply Chain and Strategy at AstraZeneca, a position she held from 2015. Roles at the company also include Vice-President Cardiology - Global Product and Portfolio Strategy, Commercial Director - Eastern Europe, Marketing Company President Hungary, where she led a major change programme to drive future success and Global Vice President, Group Public Affairs.

Jenny has also been CEO of the charity Barretstown, transforming it into a successful leading children's charity. Her work at the charity resulted in her being asked by Barretstown board member Dermot Gleeson, Chairman of Allied Irish Bank, to join the Board of the bank as a Non-Executive Director, a role she held from 2004 to 2010. Jenny has a BSc in Physiology and Pharmacology from the University of Southampton.

Jan Boone, Chairman of Animalcare Group plc, said: "We are excited to welcome Jenny Winter, whose strong and varied international experience make her ideally placed to continue to realise the full benefits of the recent reverse merger and continue to implement our clear strategy for growth in the attractive animal health market.

"The Board would like to thank Chris for his significant achievements as Chief Executive, overseeing the transformational merger with Ecuphar and the transition of Animalcare to an international animal health business. His extensive experience will continue to be invaluable to the Company in his new role and will be vital in the Company's plans for growth."

Jenny Winter, Chief Executive Officer Elect of Animalcare Group plc, said: "I am delighted to be joining Animalcare at a very exciting time for the Company. My focus will be on accelerating the strong foundation for growth that has been already laid by the Board and management team, focusing on consolidation, product development and maximising the potential of the Group's unique and highly compelling animal health portfolio."

Chris Cardon, Chief Executive Officer/Strategy Officer of Animalcare Group plc, said: "I am proud to have led Animalcare through a very significant period of development for the business. I am pleased to hand over the reins of the Company to Jenny to allow me to focus on the strategic vision for the business and I am confident that she is the right candidate to lead Animalcare in its next stage of its growth and development. I look forward to working with her closely to ensure the continued success of the Group and to drive sustained growth of the business."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 687

Chris Cardon, Chief Executive Officer

 

Chris Brewster, Chief Financial Officer

 

 

 

 

 

Panmure Gordon (Nominated Adviser & Broker)

Tel: 020 7886 2500

Corporate Finance

 

Freddy Crossley / Emma Earl

 

 

Corporate Broking

 

 

James Stearns

 

 

 

 

 

Consilium Strategic Communications

Tel: 020 3709 5700

 

 

Amber Fennell

 

animalcare@consilium-comms.com

 

Chris Welsh

 

 

Olivia Manser

 

 

     

 

Additional information

 

In accordance with paragraph (h) of Schedule 2 of the AIM Rules for Companies, the following information required to be disclosed in relation to Ms Winter is set out below.

 

Jennifer Ann Julia Winter (also known as Hynes and Winter-Hynes), aged 58, is not and has not been a director or partner of any companies within the previous five years. Also, Ms Winter currently holds no beneficial interest in the Company.

 

There is no further information required to be disclosed in respect of Ms Winter under Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

 

About Animalcare Group plc

Animalcare is a pan-European sales, marketing and product development company focused on the veterinary and animal health sectors. The Company has operations across Europe with direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany), and exports to approximately 40 markets worldwide through global partnerships. The Company sells over 300 products including pharmaceuticals, vaccines and nutraceuticals. Animalcare has a diverse pipeline of products in development and a strong network of distribution and in-license partnerships. For more information, please visit: www.animalcaregroup.co.uk 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUCWRUPRUAW
Date   Source Headline
28th Feb 20247:00 amRNSDisposal of Identicare Ltd
29th Jan 202410:27 amRNSNotification of Major Holding
25th Jan 20247:00 amRNSTrading Update and Notice of 2023 FY Results
9th Nov 20232:01 pmRNSNotification of Major Holding
1st Nov 202311:38 amRNSNotification of Major Holding
12th Oct 20231:28 pmRNSExercise of Options and Total Voting Rights
5th Oct 20237:00 amRNSPDMR Dealing – Dividend Reinvestment Plan
2nd Oct 20234:42 pmRNSNotification of Major Holding
26th Sep 20237:00 amRNSInterim Results for six months ended 30 June 2023
19th Sep 20239:04 amRNSNotification of Major Holding
18th Sep 20236:23 pmRNSNotification of Major Holding
27th Jul 20237:00 amRNSHalf year Trading Update and Notice of Interims
21st Jun 20237:00 amRNSOption Exercise, Admission and Total Voting Rights
13th Jun 20233:50 pmRNSResult of 2023 AGM
19th May 20237:00 amRNS2022 Annual Report and Notice of 2023 AGM
28th Mar 20237:00 amRNS2022 Preliminary Results
26th Jan 20237:00 amRNSTrading Update and Notice of Full Year Results
21st Dec 20223:43 pmRNSNotification of Major Holding
21st Nov 20223:39 pmRNSNotification of Major Holding
14th Nov 20227:00 amRNSChange of Registered Office
20th Oct 20227:34 amRNSCorrective announcement - H1 2022 Interim Results
27th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
26th Jul 20227:00 amRNSH1 Trading Update and Notice of Interim Results
7th Jun 20225:11 pmRNSResult of 2022 AGM and changes to Board Committees
12th May 20227:00 amRNS2021 Annual Report and Notice of 2022 AGM
3rd May 20227:00 amRNSChanges to Board of Directors
29th Apr 20222:19 pmRNSGrant of options and PDMR Dealing
12th Apr 20221:40 pmRNSNotification of Major Holding
29th Mar 20227:00 amRNSFull year results 2021
24th Mar 20227:00 amRNSAnimalcare and Orthros form VHH R&D collaboration
10th Feb 20222:46 pmRNSAppointment of Non-Executive Director
25th Jan 20227:00 amRNSTrading Update & Notice of Full Year Results
8th Nov 20211:27 pmRNSGrant of options
26th Oct 20219:27 amRNSNotification of Major Holding
5th Oct 20213:22 pmRNSNotification of Major Holding
28th Sep 20217:00 amRNSInterim Results H1 2021
16th Sep 202110:46 amRNSNotification of Major Holding
9th Sep 20211:44 pmRNSNotification of Major Holding
2nd Aug 20217:00 amRNSNotification of Total Voting Rights
30th Jul 202112:00 pmRNSNotification of Major Holding
22nd Jul 20217:00 amRNSHalf Year Trading Update and Notice of Results
15th Jul 20214:11 pmRNSNotification of Major Holding
15th Jul 20217:00 amRNSDirector/PDMR Notification
12th Jul 20214:15 pmRNSNotification of Major Holding
12th Jul 20214:00 pmRNSNotification of Major Holding
12th Jul 20213:35 pmRNSNotification of Major Holding
12th Jul 202111:04 amRNSNotification of Major Holding
12th Jul 20217:00 amRNSExercise of options
9th Jul 20214:59 pmRNSNotification of Major Holding
9th Jul 20213:20 pmRNSNotification of Major Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.